Interview with Giuseppe Pantaleo, Horizon Magazine

Scientists remain vigilant for new Covid-19 variants while improving the ability to predict complications

Professor Giuseppe Pantaleo, CoVICIS Principal Investigator and Chief of the Division of Immunology and Allergy at Centre Hospitalier Universitaire Vaudois in Switzerland, spoke with Vittoria D’Alessio from Horizon Magazine to discuss the ongoing work of researchers to monitor populations for new variants of concern. The article features a profile of CoVICIS and the EU-funding COVIRNA project which is devising a test to predict who is most likely to develop cardiovascular complications.

We might have good control over the pandemic – and the vaccine has played a major role in achieving this – but the virus continues to persist, and the situation is still very dynamic. It’s critical for us to keep monitoring populations for new variants. We need to know the impact each mutation has on the effectiveness of vaccines and treatments so we can be prepared for what is coming next and put in place new measures to control the spread.

Professor Giuseppe Pantaleo
CoVICIS Principical Investigator and Chief of the Division of Immunology and Allergy, CHUV, University of Lausanne, Switzerland

  CoVICIS is funded by the European Union’s Horizon Europe Research and Innovation Programme under grant nr 101046041

Our partners